semaglutide in sterling heights Zepbound vs vs Wegovy: What's the Difference? Medical Weight Loss Metro Detroit

Osteoarthritis: weight + pain In people with obesity and knee osteoarthritis , once-weekly semaglutide 2.4 mg produced: Greater weight loss Significantly larger reductions in knee pain Improved function Obstructive sleep apnea (OSA) The SURMOUNT-OSA phase 3 trials showed that tirzepatide (Zepbound) in adults with obesity and moderate-to-severe OSA: Reduced the apneahypopnea index (AHI) Lowered body weight, hypoxic burden, hsCRP, and systolic BP Improved sleep-related patient-reported outcomes compared with placebo In December 2024, the FDA approved Zepbound as the first medication specifically indicated for moderate-to-severe OSA in adults with obesity , alongside diet and physical activity

They mimic a gut hormone that tells your brain, 'I'm full.' This dramatically reduces 'food noise'that constant, nagging chatter about your next meal

By reducing fat mass and improving adipose tissue signaling, retatrutide may: Lower inflammatory cytokines Improve adipose tissue health Reduce metabolic stress on the liver, pancreas, and cardiovascular system These effects support broader metabolic improvement beyond cosmetic weight loss

Foundayo Foundayo is made by Eli Lilly, the same manufacturer behind the injectable GLP-1 medications Mounjaro and Zepbound

NEWS IN PHOTOS: "Local" 6 Rockbridge Co

Syed is recognized as a leading voice in obesity medicine throughout the Rochester community